logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
N

Naomi B. Haas

University of Pennsylvania
H指数:54
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

21 A Phase II Study of Total Consolidative Metastasis-and-Primary Directed Therapy for Renal Cell Carcinoma (NCT06770855)

21 肾细胞癌完全巩固性转移灶及原发灶导向疗法的II期研究（NCT06770855）

Oncologist
IF4.2
2026-09-020
OAAI
Henry Litt; Jeffrey Shevach; Ryan Cobb; Arun Goel; Thomas Guzzo; Daniel Lee; Lin Mei; Ronac Mamtani; Kara Maxwell; Vivek Narayan; John Nikitas; Phillip Pierorazio; Sunil Singhal; Michael Soulen; Spyros Stavropoulos; Samuel Takvorian; Neha Vapiwala; E Paul Wileyto; Alexander Huang; Naomi Haas
Adjuvant pembrolizumab for the treatment of clear cell renal cell carcinoma: Five-year results from the phase III KEYNOTE-564 study

辅助治疗用帕博利珠单抗治疗透明细胞肾细胞癌：KEYNOTE-564 III期研究五年结果

Annals of Oncology
IF65.4
2026-08-260
PRE
N.B. Haas; T.B. Powles; P. Tomczak; S.H. Park; B. Venugopal; S.N. Symeonides; T. Ferguson; Y-H. Chang; J-L. Lee; P. Sawrycki; N. Sarwar; H. Gurney; M. Gross-Goupil; J.M. Burke; G. Doshi; J. Cornell; J.E. Burgents; R.F. Perini; T.K. Choueiri
OncoEducate: A Pilot Study of Generative AI to Enhance Patient-Clinician Communication in Genitourinary Cancer Care

OncoEducate：一项关于利用生成式AI增强泌尿生殖系统癌症护理中患者与临床医生沟通的试点研究

The Oncologist
IF0
2026-05-010
OA
Henry K Litt, MD; Amelia Wodzinski, CRNP; Pearl Subramanian, MD; Mackenzie Donovan, RN; Neha Vapiwala, MD; Vivek Narayan, MD, MS; Lin Mei, MD; Samuel Takvorian, MD, MSHP; Naomi B Haas, MD; Ravi B Parikh, MD, MPP; Ronak Mistry, DO; Ronac Mamtani, MD, MSCE
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers

高级泌尿肿瘤共识会议（AUC3）2025：肾细胞癌和尿路肿瘤管理的专家共识

CA: A Cancer Journal for Clinicians
IF0
2025-12-130
OAAI
Rana R. McKay MD; Sumanta Pal MD; Wanling Xie MS; David Aggen MD, PhD; Laurence Albiges MD, PhD; Andrea Apolo MD; Michael B. Atkins MD; Rick Bangs MBA, PMP; Kathryn E. Beckermann MD, PhD; Joaquim Bellmunt MD, PhD; Stephanie A. Berg DO; Mehmet A. Bilen MD; David Braun MD, PhD; Maria I. Carlo MD; Jason Efstathiou MD, DPhil; Matthew Galsky MD; Petros Grivas MD, PhD; Shilpa Gupta MD; Naomi Haas MD; A. Ari Hakimi MD; Hans Hammers MD, PhD; Daniel Y. C. Heng MSC; Michelle Hirsch MD, PhD; Gopakumar Iyer MD; Eric Jonasch MD; Vadim S. Koshkin MD; Oleksandr Kryvenko MD; Bryan Lewis JD; Roger Li MD; Surena Matin MD; Benjamin Maughan MD, PharmD; David F. McDermott MD; Bradley McGregor MD; Joshua Meeks MD, PhD; Matthew Milowsky MD; Robert Motzer MD; Andrea Necchi MD; Dan Petrylak MD; Sima Porten MD, MPH; Thomas Powles MBBS, MRCP, MD; Brian Rini MD; Brian Shuch MD; Arlene Siefker-Radtke MD; Guru Sonpavde MD; S. Srikala Sridhar MD; Cristina Suarez MD, PhD; Chad Tang MD; Abhishek Tripathi MD; Michiel S. Van Der Heijden MD, PhD; Martin Voss MD; Wenxin Xu MD; Tian Zhang MD; Jonathan Rosenberg MD; Toni K. Choueiri MD
Presence of tertiary lymphoid structures and exhausted tissue-resident T cells determines clinical response to PD-1 blockade in renal cell carcinoma
JOURNAL OF IMMUNOLOGY
IF3.4
2025-11-010
PRE
Wirth, Lena Vanessa; Hugaboom, Miya B.; Street, Kelly; Ruthen, Neil; Jegede, Opeyemi; Schindler, Nicholas; Shah, Valisha; Zaemes, Jacob; El Ahmar, Nourhan; Matar, Sayed; Savla, Varunika; Choueiri, Toni; Denize, Thomas; West, Destiny; Mcdermott, David F.; Plimack, Elizabeth R.; Sosman, Jeffrey; Haas, Naomi; Hurwitz, Michael E.; Hammers, Hans; Stein, Mark; Alter, Robert; Bilen, Mehmet; Signoretti, Sabina; Atkins, Michael B.; Wu, Catherine J.; Braun, David
CD163+Tumor-Associated macrophages and clinical outcomes to First-Line nivolumab therapy in patients with metastatic clear cel renal cell carcinoma: insights from the HCRN GU16-260 trial

CD163+肿瘤相关巨噬细胞与转移性透明细胞肾细胞癌患者接受一线纳武利尤单抗治疗的临床结局：来自HCRN GU16-260试验的见解

ONCOLOGIST
IF4.2
2025-10-010
OAAI
Simsek, Berkay; Paul, Morgan A.; Xie, Wanling; El Ahmar, Nourhan; Matar, Sayed; Laimon, Yasmin Nabil; RobertiDe Oliveira, Gabriel; Mohanna, Razan; Delcea, Andrew; Choueri, Toni; Braun, David; Sun, Maxine; Haas, Naomi B.; Hammers, Hans J.; Bilen, Mehmet; Stein, Mark N.; Sosman, Jeffrey A.; Freeman, Gordon J.; Wu, Catherine; Mcdermott, David; Atkins, Michael B.; Signoretti, Sabina
Presence of tertiary lymphoid structures and exhausted tissue-resident T cells determines clinical response to PD-1 blockade in renal cell carcinoma

三级淋巴结构的存在和耗竭性组织驻留T细胞决定了肾细胞癌对PD-1阻断的临床反应

ONCOLOGIST
IF4.2
2025-10-010
OAAI
Wirth, Lena; Hugaboom, Miya; Street, Kelly; Ruthen, Neil; Jegede, Opeyemi; Schindler, Nicholas; Shah, Valisha; Zaemes, Jacob; El Ahmar, Nourhan; Matar, Sayed; Savla, Varunika; Choueri, Toni; Denize, Thomas; West, Destiny; Mcdermott, David; Plimack, Elizabeth; Sosman, Jeffrey A.; Haas, Naomi B.; Hurwitz, Michael; Hammers, Hans J.; Stein, Mark N.; Alter, Robert; Bilen, Mehmet; Signoretti, Sabina; Atkins, Michael B.; Wu, Catherine; Braun, David
Immunotherapy response correlates in metastatic clear cell renal cell carcinoma from circulating cell-free epigenomes

转移性透明细胞肾细胞癌中循环游离表观基因组与免疫治疗效果的关联

ONCOLOGIST
IF4.2
2025-10-010
OAAI
El Hajj Chehade, Razane; Semaan, Karl; Zhang, Ze; Phillips, Noa; Canniff, John; Savignano, Hunter; Nawfal, Rashad; Eid, Marc; Grisham, Lexi; Prather, Rebecca; Beckermann, Katy; Vaishampayan, Ulka; Haas, Naomi; Hammers, Hans; McDermott, David; Wood, Lauren; Solley, Travis; Rini, Brian; Jonasch, Eric; Choueiri, Toni K.; Freedman, Matthew L.; Haake, Scott M.; Baca, Sylvan C.; Berchuck, Jacob E.
Phase 1b/2 study of batiraxcept alone and in combination with cabozantinib with or without nivolumab for advanced clear cell renal cell carcinoma

I期b/II期研究：评估batiraxcept单药及联合cabozantinib（无论是否联合nivolumab）治疗晚期透明细胞肾细胞癌的疗效。

ONCOLOGIST
IF4.2
2025-06-010
PRE
Beckermann, Kathryn E.; Shah, Neil J.; Campbell, Matthew T.; Haas, Naomi B.; Nelson, Ariel; Ornstein, Moshe C.; Mao, Shifeng; Keshava-Prasad, Holavanahalli S.; Hammers, Hans; Gao, Xin; Gourdin, Theodore; George, Saby; Hoimes, Christopher J.; Hussain, Arif; Jonasch, Eric; Rini, Brian, I; Voss, Martin H.
Tertiary Lymphoid Structures Predict Response to First-Line Nivolumab Therapy in Advanced Renal Cell Carcinoma: Findings from the HCRN GU16-260 Clinical Trial

三级淋巴结构预测晚期肾细胞癌一线Nivolumab治疗的反应: HCRN GU16-260临床试验的结果

LABORATORY INVESTIGATION
IF4.2
2025-03-010
PRE
El Ahmar, Nourhan; Simsek, Berkay; Jegede, Opeyemi; Matar, Sayed; Savla, Varunika; Laimon, Yasmin; Mohanna, Razan; De Oliveira, Gabriel Roberti; Sheshdeh, Aseman Baghari; Delcea, Andrew; Paul, Morgan; Choueiri, Toni; Xie, Wanling; Freeman, Gordon; Braun, David; Haas, Naomi Balzer; Hammers, Hans; Bilen, Mehmet; Stein, Mark; Sosman, Jeffrey; Wu, Catherine; Mcdermott, David; Atkins, Michael; Signoretti, Sabina
A Call for a Neoadjuvant Kidney Cancer Consortium: Lessons Learned from Other Cancer Types

关于建立肾癌新辅助治疗联盟的呼吁：从其他癌症类型中汲取的经验教训

EUROPEAN UROLOGY
IF25.2
2025-01-010
PRE
Bex, Axel; Jewett, Michael; Lewis, Bryan; Abel, E. Jason; Albiges, Laurence; Berg, Stephanie A.; Bratslavsky, Gennady; Braun, David; Brugarolas, James; Choueiri, Toni K.; Finelli, Antonio; George, Daniel; Haas, Naomi B.; Hakimi, A. Ari; Hammers, Hans; Hirsch, Michelle; Jonasch, Eric; Kapur, Payal; Linehan, W. Marston; Master, Viraj; Mcgregor, Bradley; Mckay, Rana R.; Mehra, Rohit; Pal, Sumantha; Poteat, Susan; Powles, Thomas B.; Rossi, Sabrina H.; Shapiro, Daniel D.; Signoretti, Sabina; Singer, Eric A.; Stravin, Chuck; Tannir, Nizar; Vaishampayan, Ulka; Xu, Wenxin
Adjuvant Everolimus in Patients with Completely Resected, Very High-risk Renal Cell Carcinoma of Clear Cell Histology: Results from the Phase 3 Placebo-controlled SWOG S0931 (EVEREST) Trial
EUROPEAN UROLOGY
IF25.2
2024-09-013
PRE
Lara, Primo N., Jr.; Tangen, Catherine; Heath, Elisabeth I.; Gulati, Shuchi; Stein, Mark N.; Meng, Maxwell; Alva, Ajjai Shivaram; Pal, Sumanta K.; Puzanov, Igor; Clark, Joseph I.; Choueiri, Toni K.; Agarwal, Neeraj; Uzzo, Robert; Haas, Naomi B.; Synold, Timothy W.; Plets, Melissa; Vaishampayan, Ulka N.; Shuch, Brian M.; Lerner, Seth; Thompson, Ian M., Jr.; Ryan, Christopher W.
Validation of Biomechanical Computed Tomography for Fracture Risk Classification in Metastatic Hormone-sensitive Prostate Cancer

生物力学ct对转移性激素敏感型前列腺癌骨折风险分级的验证

EUROPEAN UROLOGY ONCOLOGY
IF9.3
2024-08-011
OA
Lin, John K.; Hearn, Caleb M.; Getzen, Emily; Long, Qi; Lee, David C.; Keaveny, Tony M.; Jayadevappa, Ravishankar; Robinson, Kyle W.; Wong, Yu-Ning; Maxwell, Kara N.; Narayan, Vivek; Haas, Naomi B.; Takvorian, Samuel U.; Bikle, Daniel D.; Chiang, Janet M.; Khan, Amna N.; Rajapakse, Chamith S.; Morgans, Alicia K.; Parikh, Ravi B.
Safety of pembrolizumab as adjuvant therapy in a pooled analysis of phase 3 clinical trials of melanoma, non - small cell lung cancer, and renal cell carcinoma
EUROPEAN JOURNAL OF CANCER
IF7.1
2024-08-010
OAAI
Luke, Jason J.; Long, Georgina V.; Robert, Caroline; Carlino, Matteo S.; Choueiri, Toni K.; Haas, Naomi B.; O'Brien, Mary; Paz-Ares, Luis; Peters, Solange; Powles, Thomas; Leiby, Melanie A.; Lin, Jianxin; Zhao, Yujie; Krepler, Clemens; Perini, Rodolfo F.; Pietanza, M. Catherine; Samkari, Ayman; Gruber, Todd; Ibrahim, Nageatte; Eggermont, Alexander M. M.
Social Determinants of Health Mediate Racial Disparities in Cardiovascular Disease in Men With Prostate Cancer
JACC: CARDIOONCOLOGY
IF12.8
2024-06-011
OA
Demissei, Biniyam G.; Ko, Kyunga; Huang, Anran; Lee, Daniel J.; Doucette, Abigail G.; Smith, Amanda M.; Wilcox, Nicholas S.; Reibel, Jacob; Sun, Lova; Agarwal, Manuj; Haas, Naomi B.; Hollis, Genevieve; Shpilsky, Jason E.; Takvorian, Samuel U.; Vaughn, David J.; Chen, Jinbo; Hubbard, Rebecca A.; Powell-Wiley, Tiffany; Yancy, Clyde; Narayan, Vivek; Ky, Bonnie
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma

辅助Pembrolizumab治疗肾细胞癌的总生存率

NEW ENGLAND JOURNAL OF MEDICINE
IF78.5
2024-04-1840
PRE
Choueiri, T. K.; Tomczak, P.; Park, S. H.; Venugopal, B.; Ferguson, T.; Symeonides, S. N.; Hajek, J.; Chang, Y-H; Lee, J-L; Sarwar, N.; Haas, N. B.; Gurney, H.; Sawrycki, P.; Mahave, M.; Gross-Goupil, M.; Zhang, T.; Burke, J. M.; Doshi, G.; Melichar, B.; Kopyltsov, E.; Alva, A.; Oudard, S.; Topart, D.; Hammers, H.; Kitamura, H.; McDermott, D. F.; Silva, A.; Winquist, E.; Cornell, J.; Elfiky, A.; Burgents, J. E.; Perini, R. F.; Powles, T.
Treatment-free survival outcomes from the phase II study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (HCRN GU16-260-Cohort A)

nivolumab和savage nivolumab/ipilimumab治疗晚期透明细胞肾细胞癌的II期研究的无治疗生存结果 (HCRN GU16-260-Cohort A)

JOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
2024-04-112
OAAI
Atkins, Michael B.; Jegede, Opeyemi A.; Haas, Naomi B.; Mcdermott, David F.; Bilen, Mehmet A.; Stein, Mark; Sosman, Jeffrey; Alter, Robert; Plimack, Elizabeth R.; Ornstein, Moshe C.; Hurwitz, Michael; Peace, David J.; Einstein, David; Catalano, Paul J.; Hammers, Hans; Regan, Meredith M.

研究方向

暂未获取到该数据
T
Toni K. Choueiri
H 指数:149论文数:2,478被引数:12.6万
R
Robert G. Uzzo
H 指数:92论文数:1,158被引数:3.6万
H
Hans J. Hammers
H 指数:61论文数:403被引数:2.6万
R
Robert S. DiPaola
H 指数:58论文数:383被引数:1.9万
J
Jeffrey A. Sosman
H 指数:122论文数:904被引数:12.7万
V
Vivek Narayan
H 指数:32论文数:305被引数:3,859
N
Neha Vapiwala
H 指数:40论文数:453被引数:6,987
D
David F. McDermott
H 指数:109论文数:1,058被引数:8.8万
R
Robert J. Motzer
H 指数:148论文数:1,602被引数:12.3万
E
Elizabeth R. Plimack
H 指数:79论文数:766被引数:4.8万